The sales are routine and immaterial relative to market cap. The derivative exercises and same-day sales pattern suggest tax withholding or 10b5-1 plan activity rather than a bearish view. No action warranted — monitor for any larger unplanned insider sales in coming weeks.
Price Chart
Executive Summary
GeneDx Holdings CEO Katherine Stueland and CFO Kevin Feeley sold a combined $419K in open-market shares on September 9, 2026, at $84.22 per share. The sales followed non-cash derivative exercises by both executives on the same day, suggesting a tax- or liquidity-driven pattern rather than a coordinated bearish signal. At $2.5B market cap, the sales represent ~0.017% of market cap — well below the 0.1% materiality threshold.
Key Financial Metrics
Key Facts
- CEO Stueland sold 3,692 shares at $84.22 for $311K
- CFO Feeley sold 1,285 shares at $84.22 for $108K
- Both executives exercised derivative options at $0 on the same day before selling
- Total open-market sales of $419K represent ~0.017% of $2.5B market cap
- No open-market purchases in the cluster
- Sales occurred on the same day at the same price, consistent with a single trading plan or tax-related sale
Financial Impact
$419K in insider sales, representing 0.017% of market cap — immaterial
Risk Factors
- If additional unplanned insider sales emerge in the next 30 days, the pattern could shift from routine to concerning
- The stock has been volatile (prior reports show large swings); insider sales near highs could signal caution if repeated
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-WGS-1789193556396 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | Insider Cluster | $85.27 $101.10 | ▲ +18.57% | ▲ +18.79% | $73.09 (−14.28%) |
Sep 1, 2026 4w ago | 144 | $86.72 $83.96 | ▼ −3.18% | ▼ −2.22% | $73.09 (−15.72%) |
Jul 27, 2026 9w ago | Press Release | $61.88 $67.86 | ▼ −9.66% | ▼ −7.39% | $73.09 (−18.12%) |
Jul 23, 2026 10w ago | Press Release | $63.38 $68.96 | ▼ −8.80% | ▼ −8.33% | $73.09 (−15.32%) |
Jun 16, 2026 15w ago | 8-K | $60.60 $58.08 | ▼ −4.16% | ▼ −1.93% | $73.09 (+20.61%) |
Jun 11, 2026 16w ago | Institutional Cluster | $59.92 $59.01 | ▼ −1.52% | ▼ −2.19% | $73.09 (+21.98%) |
Jun 8, 2026 16w ago | Insider Cluster | $56.33 $61.32 | ▲ +8.86% | ▲ +6.45% | $73.09 (+29.75%) |
May 20, 2026 19w ago | Insider Cluster | $47.33 $50.15 | ▲ +5.96% | ▲ +4.36% | $73.09 (+54.43%) |
Mar 26, 2026 27w ago | Insider Cluster | $61.35 $66.20 | ▼ −7.91% | ▼ −6.27% | $73.09 (−19.14%) |
Mar 4, 2026 30w ago | Insider Cluster | $79.47 $85.10 | ▼ −7.08% | ▼ −8.42% | $73.09 (+8.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access